Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic antispasmodic agent. It works by blocking muscarinic receptors in the smooth muscle of the gastrointestinal tract, reducing spasms and associated pain.
## Primary Indications
* Symptomatic treatment of abdominal cramps and spasms.
* Management of irritable bowel syndrome (IBS) symptoms.
## Adult Dosing
* **Oral:** 20 mg four times daily.
* **Parenteral (IV/IM/SC):** 20 mg every 6 to 8 hours as needed. Maximum single dose is typically 100 mg, and maximum daily dose is 200 mg (this may vary by formulation and local protocol).
## Pediatric Dosing
Dosing in children is not well-established and should be approached with caution.
* **Children 6-12 years:** Oral: 10 mg three times daily.
* **Infants and younger children:** Parenteral administration can be used. Specific doses vary significantly by weight and indication and require careful calculation by a healthcare professional. A common starting point for intramuscular or subcutaneous administration in infants might be 0.3 mg/kg/dose, every 8 hours, not to exceed the adult dose. The exact pediatric dose depends on clinical judgment and local guidelines.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised in elderly patients due to potential anticholinergic side effects.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Glaucoma (especially angle-closure glaucoma).
* Myasthenia gravis.
* Prostatic hypertrophy (risk of urinary retention).
* Tachyarrhythmias.
* Gastrointestinal obstructions or paralytic ileus.
* Megacolon.
## Adverse Effects
Common adverse effects are typically anticholinergic:
* Dry mouth
* Tachycardia
* Blurred vision
* Urinary retention
* Constipation
* Drowsiness
* Skin reactions (less common)
Serious adverse effects (rare) include anaphylactic reactions.
## Key Drug Interactions
* **Other anticholinergics (e.g., tricyclic antidepressants, antihistamines, antiparkinsonian drugs):** Increased risk of anticholinergic side effects.
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both agents.
* **Beta-agonists:** May counteract the bronchodilatory effects of beta-agonists.
## Monitoring
* Monitor for effectiveness in symptom relief.
* Observe for signs and symptoms of anticholinergic side effects, especially in elderly patients.
* Monitor for signs of urinary retention.
## Clinical Pearls
* Hyoscine butylbromide does not readily cross the blood-brain barrier, leading to fewer central nervous system effects compared to other anticholinergics.
* Parenteral administration provides faster onset of action for acute, severe spasms.
* Use with caution in patients with conditions that could be exacerbated by anticholinergic effects. Ensure adequate hydration is maintained.
***
*This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the current prescribing information and relevant clinical guidelines for complete details, including specific contraindications, warnings, and potential adverse effects before prescribing or administering this medication.*
